Evidence map›Paper›PMID 27717667›Full record

ReviewPreventive medicine2016

Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: A narrative review.

Allison J Carroll, Darwin R Labarthe, Mark D Huffman, Brian Hitsman

Open access · greenAbstract readReview
In one paragraph

Review in Preventive medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Alternative Tobacco Product Use in Critically Ill Patients.International journal of environmental research and public health · 2020
    Article
  4. Review
  5. Association of cigarette smoking with radial augmentation index: the Circulatory Risk in Communities Study (CIRCS).Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Allison J CarrollDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, United States.
Darwin R LabartheDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, United States.
Mark D HuffmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, United States.
Brian HitsmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, United States. Electronic address: b-hitsman@northwestern.edu.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
Targeting Depression and Nicotine Dependence to Promote Cardiovascular HealthF31HL129494 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CARROLL, ALLISON JANE · 2015 to 2016
$74k
NCI NIH HHS P30 CA060553NHLBI NIH HHS F31 HL129494
6 · The paper itself

Abstract

The purpose of this review is to emphasize the role of tobacco prevention and control in cardiovascular health (CVH) promotion and cardiovascular disease (CVD) prevention, including the importance of these endpoints for measuring the full impact of tobacco-related policies, programs, and practices. In this review, we describe an overview of tobacco control interventions that have led to substantial declines in tobacco use and the relationship between these declines with CVH and CVD. We review interventions that have had success in high-income countries (HICs) as well as those that are gaining traction in low- and middle-income countries (LMICs). We emphasize the challenges to comprehensive tobacco prevention and control strategies faced by LMICs, and highlight the special role of cardiovascular health professionals in achieving CVH promotion and CVD prevention endpoints through tobacco control. Tobacco prevention and control strategies have a strong scientific basis, yet a distinct gap remains between this evidence and implementation of tobacco control policies, particularly in LMICs. Health professionals can contribute to tobacco control efforts, especially through patient-level clinical interventions, when supported by a health care system and government that recognize and support tobacco control as a critical strategy for CVH promotion and CVD prevention. Understanding, supporting, and applying current and evolving policies, programs, and practices in tobacco prevention and control is the province of all health professionals, especially those concerned with CVH promotion and CVD prevention. A new tobacco control roadmap from the World Heart Federation provides a strong impetus to the needed interdisciplinary collaboration.

Indexed as

Health PolicySmoking PreventionCardiovascular DiseasesDeveloping CountriesHealth PersonnelHealth PromotionHumansTobacco IndustryCardiovascular diseasesGlobal healthHealth personnelSmoking cessationTobacco control

Identifiers

PMID27717667
PMCPMC5125629
OpenAlexW2529823793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.